Approvals/CIMA-AEMPS/TEICOPLANINA HIKMA 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Approved

STANDARD

TEICOPLANINA HIKMA 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 466f6753666e843b
Drug Cima Aemps Name: TEICOPLANINA HIKMA 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
Register Number: 85874
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2021-05-12
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose: 400 mg
Route Of Administration: VÍA INTRAMUSCULAR, VÍA INTRAVENOSA, VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

TEICOPLANINA

400 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 12, 2021

Approval ID

466f6753666e843b

Type

Standard